Literature DB >> 11423502

Diabetes and risk of fracture: The Blue Mountains Eye Study.

R Q Ivers1, R G Cumming, P Mitchell, A J Peduto.   

Abstract

OBJECTIVE: To examine associations between measures of diabetes and risk of fracture in a population-based sample of older Australians. RESEARCH DESIGN AND METHODS: This was a prospective study of 3,654 subjects aged 49 years and older who were residents in the Blue Mountains, west of Sydney, Australia. At baseline, subjects were asked questions about history and treatment of diabetes, and fasting blood samples were taken. Photographs were taken of the retina and lens to grade retinopathy and cataract. Details of fractures (excluding rib and vertebral fractures) were collected by a combination of self-report and medical record searches; all fractures were radiologically confirmed.
RESULTS: After 2 years of follow-up, we found that several diabetes-related factors were significantly associated (in multivariate models) with increased risk of all fractures combined, including presence of diabetic retinopathy (adjusted RR 5.4, 95% CI 2.7-10.8), diabetes duration > or = 10 years (3.3, 1.3-8.2), cortical cataract involving > or = 25% of the lens area (2.5, 1.3-4.7), and insulin treatment (5.9, 2.6-13.5). The proximal humerus was the only individual fracture site associated with diabetes. Diabetic retinopathy (10.3, 2.2-48.0), diabetes duration (for > or = 10 years duration; 11.4, 2.4-54.2), and insulin treatment (18.8, 4.0-88.7) were all associated with proximal humerus fracture.
CONCLUSIONS: These data suggest a significantly increased risk of fracture associated with diabetic retinopathy, advanced cortical cataract, longer diabetes duration, and insulin treatment. However, there are some shortcomings in this study that may limit these findings.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11423502     DOI: 10.2337/diacare.24.7.1198

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  108 in total

1.  Defects in cortical microarchitecture among African-American women with type 2 diabetes.

Authors:  E W Yu; M S Putman; N Derrico; G Abrishamanian-Garcia; J S Finkelstein; M L Bouxsein
Journal:  Osteoporos Int       Date:  2014-11-15       Impact factor: 4.507

Review 2.  Osteoporosis and diabetes mellitus.

Authors:  Angela M Inzerillo; Solomon Epstein
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

3.  Relationship between treatments with insulin and oral hypoglycemic agents versus the presence of vertebral fractures in type 2 diabetes mellitus.

Authors:  Ippei Kanazawa; Toru Yamaguchi; Masahiro Yamamoto; Toshitsugu Sugimoto
Journal:  J Bone Miner Metab       Date:  2010-02-23       Impact factor: 2.626

4.  Clinical risk factors for fracture in diabetes: a matched cohort analysis.

Authors:  Lisa-Ann Fraser; Janet Pritchard; George Ioannidis; Lora M Giangegorio; Jonathan D Adachi; Alexandra Papaioannou; William D Leslie
Journal:  J Clin Densitom       Date:  2011-08-31       Impact factor: 2.617

Review 5.  Osteoporosis and diabetes.

Authors:  Diane L Chau; Steven V Edelman; Manju Chandran
Journal:  Curr Diab Rep       Date:  2003-02       Impact factor: 4.810

Review 6.  Diabetes and fractures: an overshadowed association.

Authors:  Natasha B Khazai; George R Beck; Guillermo E Umpierrez
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2009-12       Impact factor: 3.243

7.  Spinal deformity index in patients with type 2 diabetes.

Authors:  C Di Somma; M Rubino; A Faggiano; L Vuolo; P Contaldi; N Tafuri; N Tafuto; M Andretti; S Savastano; A Colao
Journal:  Endocrine       Date:  2012-12-11       Impact factor: 3.633

8.  Fracture risk in type 2 diabetes: update of a population-based study.

Authors:  L Joseph Melton; Cynthia L Leibson; Sara J Achenbach; Terry M Therneau; Sundeep Khosla
Journal:  J Bone Miner Res       Date:  2008-08       Impact factor: 6.741

9.  Long-term fracture risk following renal transplantation: a population-based study.

Authors:  Line M Vautour; L Joseph Melton; Bart L Clarke; Sara J Achenbach; Ann L Oberg; James T McCarthy
Journal:  Osteoporos Int       Date:  2003-12-09       Impact factor: 4.507

10.  Low serum level of the endogenous secretory receptor for advanced glycation end products (esRAGE) is a risk factor for prevalent vertebral fractures independent of bone mineral density in patients with type 2 diabetes.

Authors:  Masahiro Yamamoto; Toru Yamaguchi; Mika Yamauchi; Toshitsugu Sugimoto
Journal:  Diabetes Care       Date:  2009-09-14       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.